|
HealthHIV Learning Management System
Search results: 185
Please complete the course at your own pace.
**This course is no longer offering CE credits.**
Track Description: Session Title: Best Practices in Learning and Curriculum Development to Support Holistic Health Among MSM of Color Session Description: Black men who have sex with men (Black MSM) are among the highest risk groups for contracting HIV in the United States. Estimates indicate that nearly a quarter of Black MSM who are seronegative at age 18 will have HIV by the time they are age 25, and data from the CDC indicate that young Black MSM are almost four times more likely than their White or Hispanic peers to be HIV positive. This session provides health care workers and other stakeholders valuable skills in understanding how providers can overcome internal biases and link BMSM with HIV and those at high risk for HIV into testing, treatment, and care. This session will detail best practices to increase provider health literacy, enhance cultural mindfulness, increase collaboration amongst providers statewide, and develop and implement quality improvement projects as a multi-regional approach for improved health outcomes for Black MSM. It is essential for community-based organizations, federally-qualified health centers, and other organizations engaging Black MSM in any HIV prevention and treatment service. Participants will hear of a training that helps providers breakdown and overcome dominant, heternormative notions of Black masculinity, which often intersect with racism and violence, resulting in powerful stereotypes about men of color. Participants also will learn how that MSM of color described as “hard to reach” often are blocked by psychosocial and structural barriers determinants, such as racism, stigma, lack of cultural mindfulness, and other psychosocial barriers. Providers must address these barriers to effectively engage this population in services. Participants also will learn about a hands-on coaching and peer support program that addresses structural issues in HIV care and reduces HIV disparities experienced by Black MSM. Session Learning Objectives: Describe the social determinants that undermine the engagement, recruitment, and retention of Black MSM in health care; etail how social norms around masculinity support the creation and dissemination of stereotypes that make it hard for others to hear and understand the lived experiences and stories of individuals, including those of men of color, that do not align with the dominant story/culture of masculinity; Detail the strategies that were used to employ evidenced-based practices in healthcare settings; Outline diverse methods to engage and retain Black MSM in HIV prevention and treatment services; Discuss best practices to increase cultural mindfulness of service providers who work with Black MSM; Enumerate strategies to increase statewide (or multi-regional) collaboration among HIV service providers; and Explain how to develop and implement quality improvement projects to mitigate health disparities among Black MSM Session #2: Session Title: MSM of Color: Engagement and Community Collaboration Session Description: Black bisexual, gay, and men who sex with men (BGM) are less likely than their white counterparts to access and use biomedical interventions, such as pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) to reduce their lifetime risk of acquiring HIV. Organizations serving this population often describe BGM as a “hard to reach high risk population”. Session Learning Objectives: Describe the lived experiences and social determinants that undermine use of biomedical interventions and engagement in care among BGM; Discuss wellness and resilience among BGM from a sociocultural-reality framework; Describe the differences in overall wellness between BGM and other populations in the U.S.; Detail current beliefs held by providers concerning the reluctance of BGM to engage in health care services and biomedical HIV prevention approaches (PrEP and PEP), in particular; Discuss culturally-appropriate digital marketing approaches and how they can be used to recruit BGM into care and encourage use of PrEP and PEP; Leverage diverse qualitative and qualitative approaches to collect and analyze data in order to understand the population’s needs; and Detail how to create and sustain safe spaces for BGM that support retention in care and use of PrEP and PEP Session #3: Session Title: MSM of Color: Developing and Supporting Peer Navigation to Improve MSM Engagement and Retention in Care Session Description: Participants in this training will learn how the lived experiences and social determinants of Black men who have sex with men across can inform how they appraoch and are impacted by peer navigation. Speakers will discuss training elements essential to successful peer navigation training: HIV 101, HIV testing, social determinants of health, motivational interviewing, drug resistance and adherence to HIV treatment, entry into and retention in care, stigma, and implicit bias. Themes of holistic health, and their relationship to social network support and peer navigation, will be outlined. Session Learning Objectives: Explain the need for a peer navigation training programs, and how they are developed and implemented; Detail how a peer navigation training can help peers apply knowledge in their work with clients; connected peers to each other; and enable them to help clients move through the continuum of care more efficiently; and Describe the social determinants that inform BMSM’s uptake of health services and peer navigation support. Session #4: Session Title: MSM of Color: Expanding HIV Prevention and Care Opportunities Session Description: This session will discuss barriers to dissemination and uptake of preexposure prophylaxis (PrEP) undetectable=untransmittable (U=U) among men who have sex with men of color (MSMOC). To understand this issue, speakers will discuss cultural competency and its impact on the uptake of service delivery among medically LGBTQ+ populations. Engagement and retention of LGBTQ+ persons in care is vital to improving health outcomes among this among this population, while reducing HIV transmissions. Creating and delivering a curriculum that teaches cultural competency to providers services LGBTQ+ persons, however, has proven challenging. Members of the healthcare workforce are just as diverse as the communities they serve. They bring their own beliefs and biases about LGBTQ+ persons and how to engage them in care. To address this issue, the DC Health Department worked with HealthHIV to create a training for providers that address how to deliver culturally-competent services for individuals within the LGBTQ+ community. Participants attending this presentation will learn about the journey of creating this curriculum, from development to implementation. Session Learning Objectives: Discuss the cultural barriers and impact of social media and cultural norms impact impact uptake of HIV care and prevention services; Describe the health department’s role in ensuring providers have access to culturally appropriate training materials; and Detail the development and implementation of culturally appropriate materials within the health department along with community partners.
The MSM of color track addresses the intersections of HIV, HCV, STIs, and LGBT health among MSM of color, particularly among racial and ethnic minority groups in underserved and disenfranchised communities. Sessions in this track stress the importance of building the capacity of the healthcare workforce through multi-stakeholder informed learning and curriculum development; engagement and collaboration informed by quantitative and qualitative data; peer navigation programs based on community-based participatory action research-informed approaches; and stakeholder engagement supporting greater uptake in HIV prevention approaches among underserved perspectives.
Session #1:
In this session, participants will learn innovative approaches to engaging MSM across in HIV prevention, treatment, and support services through the recruitment, hiring, and training of appropriate team members; using data to drive HIV prevention practices; and engaging and retaining trained members of the client population in prevention, education, testing, treatment and social support services. We will also highlight how to create a network and base of engagement in areas where YMSM live, are educated and employed at a higher rate.
This module covers the various health and social needs of previously incarcerated individuals with substance use disorders upon returning home to their Washington, D.C. communities. It discusses the resources available to returning citizens, the challenges that these individuals may face, and some strategies providers can use to reduce these challenges. The module also reviews policy recommendations that can better support an individual’s transition from incarceration to reintegration in the community.
Learning Objectives
- Identify the physical health, mental health, and social needs of citizens returning to their Washington, D.C. communities following incarceration.
- Discuss the existing resources available to returning citizens in Washington, D.C.
- Assess common barriers faced by returning citizens that impede their successful reintegration into their communities.
- Consider policy changes that could remediate existing barriers and facilitate the successful transition back into the community.
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Please review the content below at your own pace.
Release Date: September 26, 2023
Expiration Date: September 26, 2024
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe 3 indications for nPEP use
- Identify the key baseline and follow up clinical/laboratory assessments for nPEP
- Explain when and how to prescribe nPEP to PrEP
- Identify resources and guidelines for prescribing nPEP
Faculty
Chris Bositis, MD-Clinical Director for the National Clinician Consultation Center and Associate Professor of Family and Community Medicine at UCSF
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This module provides insights on and discusses evidenced-based strategies to promote harm reduction among the youth population. Professionals gain an understanding and knowledge of the foundational principles central to harm reduction, in addition to substance-use trends among youth and strategies and tools to use when working with young adults.
Faculty: Keristen Mazyck, LISW-CP, HIVPCP
Learning Objectives:
At the end of this webinar, you will be able to:
- Identify foundational principles central to harm reduction.
- Describe harm reduction strategies tailored to youth.
- Discuss substance use trends among youth and adolescents.
- Discuss the prevalence of substance use among youth.
- Describe harm reduction issues specific to youth experiencing mental and/or behavioral health conditions.
NOTE: This module does NOT offer continuing education credits.
**This course is no longer offering CE credits.**
This module reviews the impact of diet and chronic illness on pain. It assists providers by improving their ability to discuss various evidence-based diets that can help to alleviate pain.Learning Objectives
- Discuss three dietary changes that will benefit pain patients
- Discuss two changes in physiology that enable dietary modifications to improve health and pain
- Counsel patients on preliminary dietary changes for pain
Welcome from Congresswoman Eleanor Holmes Norton
Congresswoman Eleanor Holmes Norton, now in her fifteenth term as the Congresswoman for the District of Columbia, is the Chair of the House Subcommittee on Highways and Transit. She serves on two committees: the Committee on Oversight and Reform and the Committee on Transportation and Infrastructure.
Before her congressional service, President Jimmy Carter appointed her to serve as the first woman to chair the U.S. Equal Employment Opportunity Commission. She came to Congress as a national figure who had been a civil rights and feminist leader, tenured professor of law, and board member at three Fortune 500 companies. Congresswoman Norton has been named one of the 100 most important American women in one survey and one of the most powerful women in Washington in another. The Congresswoman’s work for full congressional voting representation and for full democracy for the people of the District of Columbia continues her lifelong struggle for universal human and civil rights.
Keynote by Harold J. Phillips
Harold J. Phillips, MRP, Director of the White House Office of National AIDS Policy (ONAP). In this position, he leads the effort to set the Administration’s domestic HIV/AIDS priorities. This includes monitoring and implementing the National HIV/AIDS Strategy (NHAS), consulting with the Office of Management and Budget, coordinating with others on the Domestic Policy Council, the National Security Council, and the Office of the Global AIDS Coordinator to ensure America’s response to the HIV epidemic is accelerated, comprehensive and reflective of the lived experiences of those at risk of and living with HIV. This work is done to reduce the number of new HIV transmissions, improve the quality of life for people living with HIV and end the HIV epidemic.
Prior to joining the White House, Mr. Phillips served as the Chief Operating Officer for the Ending the HIV Epidemic Initiative in the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health. There, he coordinated the initiative’s activities across the Department’s operating divisions.
SPEAKERS
Eleanor Holmes Norton, U.S. House of Representatives
Harold J. Phillips, Director, White House Office of National AIDS Policy
Visit sync2021.org/credits for information on claiming and receiving CME/CE credits for this session.U=U (undetectable equals untransmissible) refers to how individuals with HIV who have undetectable viral loads cannot transmit HIV. Join DC Engage, led by HealthHIV, on Tuesday, August 29, 2023 at 12:00pm Eastern for a webinar that will provide an in-depth exploration of the U=U concept, with a focus on its application to harm reduction.
The module reviews the challenges involved in achieving viral suppression and maintaining undetectable viral loads, particularly for people who use drugs. Providers also gain an understanding of potential opportunities for promoting activities that contribute to harm reduction strategies to reduce barriers and to increase drug user health.
Learning Objectives:
At the end of this webinar, you will be able to:
- Demonstrate enhanced knowledge of U=U (undetectable and untransmissible).
- Describe the limitations to achieving viral suppression and undetectable viral loads.
- Discuss the opportunities and best practices to promote activities that support viral suppression and undetectable viral loads.
Faculty: Patrick Ingram and Bobbi Gass, MPH
NOTE: This module does NOT offer continuing education credits.This module will provide a basic understanding of how to manage performance so you can reach your greatest potential as an organization.
This plenary session will address the intersection of the social determinants of health, the global COVID-19 pandemic, national HIV, HCV, STI, and LGBTQ healthcare planning efforts, and racial and social justice issues -- and the disparate impact on health equity and long-term health outcomes among medically underserved populations. Speakers from health departments, health centers, and AIDS service organizations (ASO) leaders will discuss their efforts to advance health equity through the development and implementation of culturally-responsive HIV, HCV, STI, LGBTQ, and now COVID-19 services. A panel discussion will sync these issues and intersections, as well as their collective impact on health outcomes at the individual and population levels, particularly among racial and ethnic minorities and LGBTQ persons. Learning Objectives: Discuss how health departments, health centers, and ASOs are leveraging innovative approaches to health care delivery to advance health equity across HIV, HCV, STI, and LGBTQ health; Describe how these efforts intersect with the social determinants of health and the current healthcare landscape, most notably the global COVID-19 pandemic and the national response to issues of racial and social justice; and Detail how these organizations have synced efforts across the local, state, and Federal levels to improve health outcomes at the individual and population levels, particularly among underserved racial/ethnic and LGBTQ populations.
This plenary will sync government agencies on Ending the HIV Epidemic (EHE) initiative during COVID-19. Ending the HIV Epidemic: A Plan for America (EHE) set an ambitious goal of harnessing the most powerful HIV prevention and treatment tools and leveraging advanced surveillance strategies to end the HIV epidemic in the United States by 2030. COVID-19 has complicated efforts as much of the public health workforce has been diverted to assist with the pandemic response. Hear from the lead EHE implementers, CDC, HRSA, BPHC, SAMHSA, HUD, and IHS as the leaders of the government health care agencies will discuss the latest updates on the Ending the HIV Epidemic implementation and how the community refocuses and re-engages in EHE midst of COVID-19. Federal leaders will discuss how their agencies are advancing the EHE initiative while responding to the COVID-19 pandemic. Learning Objectives: Discuss and sync activities and approaches of the federal agencies on Ending the HIV Epidemic implementation. Identify how COVID-19 has impacted Ending the HIV Epidemic implementation. Discuss how the federal agencies are leveraging responses to address COVID-19.
During this dynamic plenary, presenters will provide insights on the clinical, structural, and practical aspects of HIV prevention and care among aging populations. The clinical section will cover data and contextualize the needs of aging populations, prevention, and HIV care. The structural component will review health systems and best practices within care coordination for aging PWH. The practical component will provide patient advocate insights on aging, HIV, and comprehensive prevention for people over 50. Explain the implications of age on HIV disease progression Discuss how provider and consumer alignment impacts the care coordination of people aging with HIV Describe the structural factors that impact the provision of care for people aging with HIV Discuss the aging patient's perspective of HIV care coordination
Learning Objectives:
Identify HIV prevention and care services for people aging with HIV
Plenary 3: SYNCing on a National PrEP Program Through Community Advocacy and Innovation
Leveraging and aligning community involvement as a way to drive collaborative public health responses is vital to meaningfully address social determinants of health. And while today’s breakthroughs in several arenas have improved health care delivery and patient outcomes for many, we need community advocacy to capitalize on the science that sustains our health, including HIV prevention science. This session takes a critical look at innovative ways communities act as public health force-multipliers, through the creation of and advocacy for a National Pre-Exposure Prophylaxis (PrEP) Program that would increase equity and accessibility to this revolutionary HIV prevention tool.Plenary 3: SYNCing to End the Epidemics Through Transgender Health
This plenary session explores lessons learned, challenges and strategies for increased engagement within Transgender Communities to ensure retention in both treatment and prevention services.
SPEAKERS
Diana Oliva, Associate Director Community Engagement, Gilead Sciences
Mimi Shelton, Director of Trans Initiatives, Destination Tomorrow
Aryah Lester, Deputy Director, Transgender Strategy Center
Bamby Salcedo, President & Chief Executive Officer, Translatin@ Coalition
Zakia McKensey, Nationz Foundation
Plenary 4: SYNCing Resources and Action to Address the Socioeconomic Determinants of Syndemics and Epidemics
Research has long shown that epidemics and syndemics, including HIV, hepatitis C, sexually-transmitted infections, MPV, and COVID-19, disparately impact underserved, disenfranchised groups. These populations, which encompass racial and ethnic minorities, sexual and gender-diverse persons, substance users, and others, represent historically underserved populations. These groups often experience limited access to basic resources, including housing, food, housing, employment, and education, compounded by the stress associated with overlapping stigmas, such as racism, HIV stigma, and homophobia. Mitigating the impact of epidemics and syndemics requires a synchronized, syndemic approach that facilitates coordination, collaboration, investment, and innovation across local, state, and federal partners. Detailing the complex, intersectional social, political, and economic forces driving epidemics and syndemics in underserved communities is key to mitigating and ultimately eliminating them.
Speakers will describe how their agencies sync resources, including staff, funding, and knowledge, with Federal, state, and local stakeholders to address epidemics and syndemics – specifically those systemic and structural factors that undermine engagement, access, and use of clinical, behavioral, and support services. In addition, they will detail their current work to support and expand current evidence-based services and interventions that break down organizational silos and maximize impact on the social determinants of health.
The epidemics of HIV, sexually-transmitted diseases (STDs), hepatitis C (HCV), opioid misuse and overdose are widely recognized as a syndemic in the U.S. Access to health care services and medication-assisted treatment of opioid use disorders, income inequality, housing disparities, intensity of policing activities, employment status, and healthcare policies, are all related to the prevalence of substance misuse, overdoses, infection risk and morbidity. With the COVID-19 virus overwhelmingly targeting people who would already be vulnerable to disease, it is important to also examine how its interaction with other epidemics may exacerbate the disease burden in certain populations and increase health vulnerability. Panelists will highlight the importance of examining and addressing structural factors, health disparities and health equity to respond to the syndemic of HIV, HCV, opioids, and COVID-19 and how structural factors are addressed through intervention and policy to reduce vulnerability of at-risk areas and populations. List the HIV, hepatitis C (HCV), opioid misuse, and overdose epidemics as a syndemic, and examine the intersection of COVID-19. Identify how health disparities exacerbate syndemics in vulnerable areas and populations. Discuss strategies to address structural factors impacting vulnerable areas and populations in order to respond to the syndemics.
Learning Objectives:
Plenary 5: SYNCing Strategies for Improving Black Women’s Health
This session will begin by honoring three trail blazers in the HIV field. Their legacies have had a significant impact on Black women’s health and lives. Black women in the U.S. are disproportionately impacted by HIV and STIs. Identifying strategies that synchronize the state of HIV prevention with tools that engage and develop skills for communities and providers will positively impact Black women’s health.
Plenary 5: SYNCing to End the Epidemics Through Science
SYNCing to end the HIV, Viral Hepatitis, STI, Opioid, and COVID-19 epidemics through science starts with a recognition that the many of the same forces and inequities that drive one epidemic fuel the rest, and that scientific advancements in one field can lead to breakthroughs in another. During the height of the pandemic, advancements in COVID-19 vaccine research advanced at a stunning pace. These advancements were expedited, in part, by the groundwork laid by more than 30 years of HIV vaccine research.
This plenary will look at the latest in scientific advances in prevention and treatment research. Speakers will provide diverse perspectives on the state of the field today, including opportunities, obstacles ahead, and priorities for actions moving forward.
SPEAKERS
Myron Cohen, Director, Institute for Global Health and Infectious Diseases/HIV Prevention Trials Network
Lawrence Corey, Fred Hutchinson Center Cancer Institute / HIV Vaccine Trials Network
Wafaa El-Sadr, University Professor of Epidemiology and Medicine at Columbia University / HIV Prevention Trials Network
Gregorio Millett, Vice President and Director, Public Policy, AmFAR
Steven Shoptaw, University of California, Los Angeles
Visit sync2021.org/credits for information on claiming and receiving CME/CE credits for this session.